Cancer Diagnostics Firm Ignite Inks $150M SPAC Merger
Precision oncology startup Ignite Proteomics LLC will merge with special purpose acquisition company Copley Acquisition Corp. in a deal valuing Ignite at a pro forma enterprise value of $150 million, the...To view the full article, register now.
Already a subscriber? Click here to view full article